Cutaneous Plasmacytosis Improved by PUVA Therapy.
- Author:
Young LEE
1
;
Eun Kyoung JEON
;
Young Joon SEO
;
Jang Kyu PARK
;
Jeung Hoon LEE
;
You Chan KIM
Author Information
1. Department of Dermatology, Chungnam National University School of Medicine, Daejeon, Korea. jhoon@cnu.ac.kr
- Publication Type:Case Report
- Keywords:
Cutaneous plasmacytosis
- MeSH:
Cyclophosphamide;
Humans;
Hyperplasia;
Korea;
Lung Diseases, Interstitial;
Lymphatic Diseases;
Male;
Melphalan;
Plasma Cells;
PUVA Therapy*;
Tacrolimus
- From:Korean Journal of Dermatology
2007;45(4):378-380
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cutaneous plasmacytosis is a rare disorder characterized by multiple red-brown plaques, mainly on the trunk, which histologically show a marked hyperplasia of mature plasma cells with no mitotic figures or cellular atypia. It is sometimes accompanied by extracutaneous symptoms like lymphadenopathy or interstitial pneumonia, but without plasma cell infiltration. Although many treatments such as corticosteroid lesional injection, cyclophosphamide, melphalan, systemic PUVA, and local tacrolimus application have been introduced for cutaneous plasmacytosis, there is no reported post-treatment data on cutaneous plasmacytosis in Korea. We report a case of a Korean male patient who was diagnosed with cutaneous plasmacytosis which was improved by PUVA therapy.
